Belgium
Belgium – Covid-19 coronavirus: ban on at-home tests lifted
22 October 2020 - Posted by: Tine Carmeliet
On 21 September 2020, the Federal Agency for Medicines and Health Products (FAMHP) announced that, as of 19 September 2020, the ban on the sale of Covid-19 at-home tests, which has been in place since March 2020, has been lifted. The at-home tests aim to detect antibodies against coronavirus SARS-CoV-2 without the intervention of a › Read More
Belgium: Covid-19 coronavirus: measures to combat medicine shortages extended again
15 October 2020 - Posted by: Veerle Pissierssens
Since April 2020, the Belgian government has taken measures to avoid medicine shortages during the Covid-19 pandemic. These measures have subsequently been revised and extended in duration four times. The measures have now been further extended until 28 October 2020 by a Federal Agency for Medicines and Health Products (FAMHP) decision dated 25 September 2020, › Read More
Belgium: Covid-19: FAMHP adopts new validation procedure for serological tests
04 October 2020 - Posted by: Tine Carmeliet
On 30 April 2020, the Federal Agency for Medicines and Health Products (FAMHP) established a verification procedure for Covid-19 tests (see our previous blog post Covid-19: measures affecting the life sciences sector (Belgium)). On 6 September 2020, FAMHP announced that it will gradually return to the conventional way of working (that is, the method being › Read More
24 September 2020 - Posted by: Veerle Pissierssens
The Belgian federal taskforce on testing and shortages commissioned a study that was launched on 28 May 2020 on the use of saliva samples as an alternative to sampling via a deep nasal swab (nasopharyngeal) to detect SARS-CoV-2 using PCR molecular detection tests. The purpose of the study, supported by Sciensano, a public research institution, › Read More
Belgium – FAMHP supports e-PIL pilot project
02 September 2020 - Posted by: Tine Carmeliet
On 17 August 2020, the Federal Agency for Medicines and Health Products (FAMHP) announced its support for the pilot project on electronic patient information leaflets, e-PIL, a project replacing the traditional paper package leaflet for certain medicines with electronic leaflets on trusted websites, which was initiated by the Belgian and Luxembourgian pharmaceutical industry in 2018. › Read More